A clinically interpretable machine learning model for early detection of diabetic retinopathy in multiple community health centers - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

A machine learning approach for the early identification of diabetic retinopathy in various community health settings

  • By

  • Juncheng Tong

  • Aifa Tang

  • Lifang Liu

  • Luyuan Zhang

  • Hainan Wang

  • Mengyuan Qu

  • Bing Liu

  • May 4, 2026

Share

Clinical Scorecard: A machine learning approach for the early identification of diabetic retinopathy in various community health settings

At a Glance

CategoryDetail
ConditionDiabetic Retinopathy (DR)
Key MechanismsMachine learning models utilizing health data to predict DR risk.
Target PopulationDiabetic individuals aged ≥18 years from community health facilities.
Care SettingPrimary care settings in low- and middle-income countries.

Key Highlights

  • Prevalence of DR was found to be 13.5% in the study cohort.
  • GLMNET model achieved an AUROC of 0.770 and AUPRC of 0.452.
  • Urine glucose identified as the most significant predictor of DR.
  • Decision curve analysis indicated net benefit for threshold probabilities of 10% to 40%.
  • Study emphasizes the need for external validation before clinical application.

Guideline-Based Recommendations

Diagnosis

  • Utilize routine fundus examinations for DR identification.
  • Employ machine learning models for risk stratification in primary care.

Management

  • Incorporate clinical variables such as diabetes type, duration, and HbA1c levels.

Monitoring & Follow-up

  • Regularly assess patients for DR risk using predictive models.

Risks

  • Low compliance with ophthalmology referrals in community settings.

Patient & Prescribing Data

Diabetic individuals from community health facilities in China.

Focus on early identification and risk stratification to prevent visual impairment.

Clinical Best Practices

  • Integrate machine learning tools into routine clinical workflows.
  • Ensure model interpretability to enhance provider confidence in decision-making.
  • Conduct prospective studies for validation of predictive models.

References

Original Source(s)

A clinically interpretable machine learning model for early detection of diabetic retinopathy in multiple community health centers

  • by Juncheng Tong, Aifa Tang, Lifang Liu, Luyuan Zhang, Hainan Wang, Mengyuan Qu, Bing Liu

  • May 4, 2026

Related Content

A machine learning model for diabetic retinopathy risk stratification using routine blood and urine parameters: insights into kidney-eye crosstalk

Update on Diabetic Disease

Upfront: Monthly reflection by Editor in Chief Diana V. Do, MD.

DME AWARE Study Defines Key Needs

Presenting results from the DME AWARE Delphi Study at the Association for Research in Vision and Ophthalmology (ARVO) meeting in Denver, Baruch D. Kuppermann, MD, PhD, director of the Gavin Herbert Eye Institute at the University of California, Irvine, described a set of consensus findings that point to unmet needs across the continuum of DME management, with particular emphasis on early intervention and noninvasive treatment options (Figure 1).